Time & Date: 4 September, 11:30 – 12:30 CEST
Chairpersons: D. Pauleikhoff GERMANY & J. Monés SPAIN
Speakers & Presentations:
D. Pauleikhoff GERMANY
11:30 Introduction
U. Chakravarthy UK
11:32 Longterm results of the IVAN-trial
11:38 Discussion
D. Barthelmes SWITZERLAND
11:40 Real-life analysis of anti-VEGF-therapy in different European countries – the FRB analysis
11:46 Discussion
J. Monés SPAIN
11:48 Pathomechanism of nAMD and consequences for longterm strategies
11:54 Discussion
D. Pauleikhoff GERMANY
11:56 Acute remodelling and longterm transformation of MNV under anti-VEGF-therapy
12:02 Discussion
A. Loewenstein ISREAL
12:04 Real world treatment of nAMD
12:10 Discussion
H. Koizumi JAPAN
12:12 Longterm perspectives of PCV under anti-VEGF therapy
12:18 Discussion
R. Spaide USA
12:20 Anti-VEGF dosing and consequences for treatment strategies
12:26 Discussion
